Tests thymosin β4 (T4) in a mouse myocardial infarction model with follow-up assessment of cardiac fibrosis. TB4 treatment post-MI reduced cardiac inflammation (TNF-α, IL-6, IL-1β), oxidative stress markers (MDA), and fibrosis-related proteins (TGF-β1, collagen I, α-SMA). Echocardiography showed improved cardiac function. Demonstrates TB4's cardioprotection extends specifically to preventing post-MI cardiac fibrosis—addressing scar formation as a distinct therapeutic endpoint beyond acute injury protection.
Wang, Fei; He, Yajuan; Yao, Naijuan; Ruan, Litao; Tian, Zhen